Posts in Patents
India’s Patent Law is No Model for the United States: Say No to No Combination Drug Patents Act
The United States is on the brink of making changes to the U.S. patent law that would be modeled on India’s Patent Law. At a …
U.S. Companies and Groups to Congress: the Section 101 Reform Draft is Good and Genes are Safe
Seventy-two companies and organizations, ranging from Tivo to Bristol-Myers Squibb and from the American Conservative Union to the Alliance of U.S. Startups & Inventors for Jobs (USIJ)— …
Dex Media: Supreme Court to Determine Scope of Judicial Review of IPR Institution Decisions
On Monday, the U.S. Supreme Court granted a petition for writ of certiorari to take up Dex Media Inc. v. Click-to-Call Technologies, LP on appeal from …
This Week on Capitol Hill: SCOTUS Grants Cert in Two IP Cases and Strikes Down Bar on Immoral/ Scandalous Marks; Plus, AI in Counterterrorism and Fintech, Copyright Office Oversight
This week on Capitol Hill and vicinity, the Supreme Court issues its decision in Iancu v. Brunetti and issues orders in several other IP cases. Meanwhile, various …
USPTO Commissioner for Patents on Life Five Years After Alice: We’ve Come a Long Way
Panelists in this past Thursday’s IPWatchdog webinar, “Dissecting Alice,” gave credit to the U.S. Patent and Trademark Office (USPTO) for the steps it has taken …
Inventors Must Oppose the Draft Section 101 Legislation
When it was announced that I would be testifying to the Senate Judiciary Subcommittee on IP about Section 101, I was surprised. Not only did they grant a …
Proper Interpretation of Section 3(d) of the Indian Patent Act Could Save Incremental Innovations of Existing Pharmaceutical Substances
The landmark judgment of the Supreme Court of India in Novartis AG & Ors. .v. Union of India & Ors. AIR 2013 SC 1311, a case that dealt with the patenting …
Other Barks & Bites, Friday June 21: China Releases National IP Strategy, Iancu Discusses Patent Eligibility, and Rubio Amendment Would Prevent Huawei Patent Suits
This week in Other Barks & Bites: Senators Tillis and Coons ask federal agencies to step up enforcement against IP theft; Senator Stabenow and Congressman Cummings ask GAO …
Last Week at the PTAB: Comcast Denied Petitions Against Rovi; Priceline.com Wins Six Joinder Motions
During the week of June 10, the Patent Trial and Appeal Board (PTAB) issued institution decisions for 21 petitions seeking inter partes review (IPR) proceedings to challenge the validity …
Congress Adds TERM Act and No Combination Drug Patents Act to List of Drug Patent Bills Being Considered
The growing debate over the effects of patents on the rising price of pharmaceuticals continues to encourage the introduction of drug pricing-focused bills in Congress over the …
After Alice: IP Stakeholders Comment on Alice’s Impact Five Years On
Since the Supreme Court issued its decision in Alice v. CLS Bank five years ago today, patent eligibility jurisprudence and practice have become increasingly chaotic—at least …
Perspective: Weakening Alice Will Weaken the U.S. Patent System’s Second Engine of Innovation
Today is Alice’s fifth birthday; some may not be celebrating, but as a birthday gift, John Vandenberg argues the decision was not new law and should …
Arguing Device-and-Method Eligibility Under the Present and Future States of U.S. Patent Law
Here's the hypothetical: A patent application has been filed for a new medical device. The device reads various physiological signals from a patient and presents, with previously …
Federal Circuit Issues Precedential Decisions On Who Can Petition for and Who Can Be Subject to Inter Partes Review
Late last week, the Federal Circuit issued Power Integrations, Inc. v. Semiconductor Components Indus., LLC and Regents of the Univ. of Minnesota v. LSI Corp. These two …
The Only Way to Counter False Claims on Patent Reform is to Enter the Debate
Coverage of the ongoing patent reform debate in the Senate Judiciary Committee by the popular press has been alarmist and largely incorrect. For example, even just yesterday—…
